Dietary factors and epigenetic regulation for prostate cancer prevention.

Advances in Nutrition
Emily HoRoderick H Dashwood

Abstract

The role of epigenetic alterations in various human chronic diseases has gained increasing attention and has resulted in a paradigm shift in our understanding of disease susceptibility. In the field of cancer research, e.g., genetic abnormalities/mutations historically were viewed as primary underlying causes; however, epigenetic mechanisms that alter gene expression without affecting DNA sequence are now recognized as being of equal or greater importance for oncogenesis. Methylation of DNA, modification of histones, and interfering microRNA (miRNA) collectively represent a cadre of epigenetic elements dysregulated in cancer. Targeting the epigenome with compounds that modulate DNA methylation, histone marks, and miRNA profiles represents an evolving strategy for cancer chemoprevention, and these approaches are starting to show promise in human clinical trials. Essential micronutrients such as folate, vitamin B-12, selenium, and zinc as well as the dietary phytochemicals sulforaphane, tea polyphenols, curcumin, and allyl sulfur compounds are among a growing list of agents that affect epigenetic events as novel mechanisms of chemoprevention. To illustrate these concepts, the current review highlights the interactions among nutri...Continue Reading

References

May 1, 1992·Preventive Medicine·H N Graham
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·N ChandarJ Locker
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·R JüttermannR Jaenisch
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y ZhangP Talalay
Feb 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·H AdlercreutzL E Vickery
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·J W FaheyP Talalay
Mar 10, 1998·Proceedings of the Society for Experimental Biology and Medicine·S MäkeläR Vihko
Dec 30, 1999·Nature Genetics·F FuksT Kouzarides
Jul 5, 2001·Cellular and Molecular Life Sciences : CMLS·J R Dobosy, E U Selker
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·S GuptaH Mukhtar
Sep 21, 2001·Biochemical and Biophysical Research Communications·S K PatraR Dahiya
Feb 19, 2002·Molecular and Cellular Endocrinology·Wayne A FritzCoral A Lamartiniere
Aug 7, 2002·The Journal of Nutrition·J Kevin DayDennis B Lubahn
Aug 31, 2002·Genes, Chromosomes & Cancer·Wolfgang A SchulzTapio Visakorpi
Sep 11, 2002·Structure·John C EvansMartha L Ludwig
Oct 9, 2002·The Journal of Nutrition·Michael S MortonBronwen A J Evans
Jul 4, 2003·The Journal of Nutrition·James R Davie
Nov 25, 2003·Cancer Investigation·Fazlul H Sarkar, Yiwei Li
Dec 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Constantine S MitsiadesKenneth C Anderson
Mar 24, 2004·The British Journal of Nutrition·Pamela J Magee, Ian R Rowland
Mar 26, 2004·The Prostate·Kalipso HalkidouCraig N Robson
Aug 18, 2004·Cancer Research·Melinda C MyzakRoderick H Dashwood
Sep 15, 2004·Biochimica Et Biophysica Acta·Long-Cheng LiRajvir Dahiya
Sep 25, 2004·The Prostate·Katrine Frønsdal, Fahri Saatcioglu
Dec 1, 2004·The Journal of Nutrition·Fazlul H Sarkar, Yiwei Li
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carmen JerónimoDavid Sidransky
Jan 20, 2005·Journal of the National Cancer Institute·Long-Cheng LiRajvir Dahiya
Mar 30, 2005·Biochemical Pharmacology·Jiuhong KangYuntao Zhang

❮ Previous
Next ❯

Citations

May 25, 2013·Cancer Causes & Control : CCC·Yueh-Ying HanEvelyn O Talbott
May 21, 2013·Cancer Letters·Thippeswamy GulappaChendil Damodaran
Jan 7, 2014·Mutation Research. Fundamental and Molecular Mechanisms of Mutagenesis·Harold TingRajesh Agarwal
Nov 29, 2013·Epigenomics·Susanne M HenningDavid Heber
Sep 21, 2013·Expert Opinion on Investigational Drugs·Zhijun WangYing Huang
Dec 26, 2015·International Journal of Molecular Sciences·Agnieszka Kaufman-SzymczykKrystyna Fabianowska-Majewska
Jun 12, 2013·Molecular Nutrition & Food Research·Marie-Hélène TeitenMarc Diederich
Nov 26, 2013·Molecular Nutrition & Food Research·Aamir AhmadFazlul H Sarkar
Jan 15, 2015·Acta Ophthalmologica·Doreen SchmidlLeopold Schmetterer
Nov 20, 2012·Pharmacology & Therapeutics·Sharmila ShankarRakesh K Srivastava
Apr 14, 2016·Lipids in Health and Disease·José Flores-SierraGertrud Lund
Jan 21, 2014·Journal of the Academy of Nutrition and Dietetics·Kathryn M Camp, Elaine Trujillo
Sep 4, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·K SahinN Sahin
Jul 10, 2012·Molecular Aspects of Medicine·F I MilagroJ A Martínez
Sep 25, 2014·BioMed Research International·Bhupender SharmaShamsher S Kanwar
Sep 1, 2016·Nature Reviews. Urology·Undraga Schagdarsurengin, Klaus Steger
Nov 5, 2016·Expert Opinion on Therapeutic Patents·H S FernandesN M F S A Cerqueira
Apr 10, 2017·Ophthalmology and Therapy·Riccardo SacconiGiuseppe Querques
Jul 1, 2017·Annals of the New York Academy of Sciences·Avinash KumarAnait S Levenson
Dec 5, 2018·Journal of the American College of Nutrition·Taylor C WallaceLinda T Vahdat
Mar 3, 2019·International Journal of Molecular Sciences·Teodora CosteaMaria-Magdalena Mocanu
May 17, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Mukesh Verma
May 16, 2013·Advances in Nutrition·Stephen BarnesHelen Kim
Nov 22, 2012·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Minju KimMihi Yang
Aug 27, 2013·Expert Review of Clinical Immunology·Lynnette R Ferguson
Jan 23, 2020·International Journal of Molecular Sciences·Dangdang LiGuangchao Sui
Aug 16, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Sepideh Arbabi BidgoliMansour Djamali Zavarhei
Dec 22, 2016·Chinese Journal of Integrative Medicine·Xue-Qing Hu, Shi-Bing Su
May 23, 2017·F1000Research·Francesco BandelloGiuseppe Querques
Jan 17, 2019·Journal of Human Hypertension·Hemlata PisalSadhana Joshi
Sep 18, 2020·Antioxidants·Shamee Bhattacharjee, Roderick H Dashwood
May 15, 2015·Cancer Prevention Research·Bernard G CipollaNicolas Mottet
Jun 19, 2013·Cancer Prevention Research·Ah-Ng Tony KongZheng-Yuan Su
Sep 7, 2019·Environment International·Jue Tao LimWei Jie Seow
Jan 30, 2021·Frontiers in Pharmacology·Ziyu WangDianwen Ju
Nov 6, 2020·Seminars in Cancer Biology·Mohammad Fahad UllahFaisel M Abuduhier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Journal of Nutrigenetics and Nutrigenomics
Thomas Prates OngSharon A Ross
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie
Palanisamy SankarAyyasamy Manimaran
© 2022 Meta ULC. All rights reserved